Nabsys closes expanded $38M equity round
Additional investment triggered by throughput-related milestone Providence RI (November 9, 2022) Nabsys, the pioneer in electronic whole-genome mapping, announced today that it has received an additional $13 million from Hitachi High-Tech as part of an expanded equity round now totaling $38 million. The expanded equity investment was triggered as a result of a technical milestone […]
Nabsys reveals new details about their next generation whole-genome mapping technology and partnership with Hitachi High-Tech
In whitepapers posted to the company’s website this week, Nabsys has provided new details into its next generation HD-Mapping™ platform. The platform provides a high-resolution electronic mapping instrument complete with solid-state nanochannel-based detectors and improved labelling chemistry with Hitachi High-Tech’s Human Chromosome Explorer™ (HCE) software as an analysis pipeline. The resulting platform provides a solution […]
Justin Bingham Joins Nabsys as Chief Commercial Officer
PROVIDENCE RI (October 19, 2022) Nabsys, the pioneer in electronic whole-genome mapping, announced that Justin Bingham has joined the company as its Chief Commercial Officer. “Justin brings highly relevant experience to Nabsys, both as a consumer of whole-genome technology and data and as a builder of commercial life sciences organizations,” said Barrett Bready, MD, Nabsys […]
Kevin DeGeeter Joins Nabsys as Chief Financial Officer
PROVIDENCE RI (July 18, 2022) Nabsys, the pioneer in electronic whole-genome mapping, announced the appointment of Kevin DeGeeter as Chief Financial Officer. “I am excited to welcome Kevin to the executive team,” said Barrett Bready, MD, Nabsys Founder and CEO. “Kevin’s deep understanding of the genomics space, as well as his reputation among investors and […]